An Open-Label, Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus (HCV) Infection Genotype 2K/1B- NINJA Study
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Proof of concept; Therapeutic Use
- Acronyms NINJA Study
- 13 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 13 Aug 2017 Status changed from not yet recruiting to recruiting.
- 15 Feb 2017 New trial record